• OPEN AN ACCOUNT
Indian Indices
Nifty
24,973.10 104.50
(0.42%)
Sensex
81,425.15 323.83
( 0.40%)
Bank Nifty
54,536.00 319.90
( 0.59%)
Nifty IT
36,183.80 927.90
( 2.63%)
Global Indices
Nasdaq
45,729.90 193.94
(0.43%)
Dow Jones
6,533.40 17.25
(0.26%)
Hang Seng
43,788.68 329.39
(0.76%)
Nikkei 225
9,225.39 -17.14
(-0.19%)
Forex
USD-INR
88.02 -0.16
(-0.18%)
EUR-INR
103.30 -0.01
(-0.01%)
GBP-INR
119.05 -0.02
(-0.01%)
JPY-INR
0.60 0.00
(-0.34%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
115.062639
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
50.85
47743.7
EPS(TTM)
Face Value()
Div & Yield %
55.42
10
1.92
 

Bajaj Steel Industries Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Aug 30,2025
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Company will be meeting with a group of Investors/Analysts on Thursday September 04 2025 for a Plant Visit from 9:30 AM to 3:00 PM; the Investor Presentation for Q1FY26 (June 2025) which is already in the public domain and available on the Companys and the Stock Exchanges website would be used during the meeting and please note that changes may happen due to exigencies on the part of Investors/Analysts/Company and the same shall be intimated accordingly.